Healthcare Associations

This page includes news coverage of primary healthcare business and policy setting associations. Find news specific to each organization by following these links: American Hospital Association (AHA), American Medical Association (AMA), College of American Pathologists (CAP), Healthcare Information Management Systems Society (HIMSS), College of Healthcare Information Management Executives (CHIME), Healthcare Financial Management Association (HFMA), and the Medical Group Management Association (MGMA). Find focused news coverage for Cardiology societies or Radiology associations.

Quality of care for heart patients does not improve in first year of ACO participation
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Cardiologists make case against routine interventions for asymptomatic severe AS
Aortic valve replacement is likely inevitable for patients with asymptomatic severe aortic stenosis. Immediately performing TAVR or SAVR, however, may not always be the answer.
Tenecteplase compares favorably to alteplase in new comparison of FDA-approved stroke drugs
Researchers explored data from nearly 80,000 patients, comparing the newest clot-busting stroke drug from Genetech with its predecessor.
Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options
A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.
Benzodiazepine use before heart surgery: Should it be embraced or restricted?
Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.

U.S. News & World Report children’s hospitals cardiology heart surgery

Children with autism face higher risk of diabetes, heart disease, dyslipidemia

Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more.

The increased use of implantable loop recorders (ILRs) is associated with identifying more bradyarrhythmias such as bradycardia, according to new findings published in JAMA Cardiology.

Increased AFib screening improves bradyarrhythmia detection—but is it a mixed blessing?

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value?

AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

Yes, COVID-19 increases a person’s diabetes risk—but vaccination may help

Patients who are vaccinated at the time of their COVID-19 diagnosis appear to face a lower risk of new-onset type 2 diabetes than patients who are not vaccinated.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

Cardiologists ask popular AI model ChatGPT to answer questions about cardiology

Can ChatGPT discuss preventive cardiology with patients? Cardiologists with Cleveland Clinic and Stanford University put the popular AI model to the test, sharing their findings in JAMA.

An example of artificial intelligence (AI) automated detection of a intracranial hemorrhage (ICH) in. a CT scan used to send alerts to the stroke acute care team before a radiologist even sees the exam. Example shown by TeraRecon at RSNA 2022.

FDA has now cleared more than 500 healthcare AI algorithms

More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

Healthcare industry reacts to PHE ending in May

MGMA and AHA discuss how the end of the PHE will impact healthcare stakeholders.

Healthcare Associations

Quality of care for heart patients does not improve in first year of ACO participation

Cardiologists make case against routine interventions for asymptomatic severe AS

Tenecteplase compares favorably to alteplase in new comparison of FDA-approved stroke drugs

Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options

Benzodiazepine use before heart surgery: Should it be embraced or restricted?